drugset / Trial / NCT07230145

A Trial of SHR-4658 in Healthy Volunteers or Volunteers With Elevated Blood Pressure

NCT07230145 ↗

Phase 1 Not yet recruiting 48 enrolled Beijing Suncadia Pharmaceuticals Co., Ltd
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a clinical study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamic and immunogenicity of single subcutaneous injection of SHR-4658 in healthy volunteers and volunteers with elevated blood pressure.

Timeline

Start
2025-11
Primary completion
2026-06
Completion
2026-07

Drugs

EvaluationDrugModalityDoseRoute
Subject SHR-4658 Unknown — Subcutaneous

Indications